283 related articles for article (PubMed ID: 27126835)
1. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
2. Specialty pharmacy services for patients receiving oral medications for solid tumors.
Stein J; Mann J
Am J Health Syst Pharm; 2016 Jun; 73(11):775-96. PubMed ID: 27126828
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
4. Building an outpatient cancer center pharmacy program across a tristate region.
Skledar SJ; Doedyns A; Yourich B
Am J Health Syst Pharm; 2015 Jan; 72(2):126-32. PubMed ID: 25550136
[TBL] [Abstract][Full Text] [Related]
5. Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
Oliveira CS; Silva MP; Miranda ÍKSPB; Calumby RT; de Araújo-Calumby RF
J Oncol Pharm Pract; 2021 Apr; 27(3):679-692. PubMed ID: 33302824
[TBL] [Abstract][Full Text] [Related]
6. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.
Deutsch S; Koerner P; Miller RT; Craft Z; Fancher K
J Oncol Pharm Pract; 2016 Feb; 22(1):68-75. PubMed ID: 25301744
[TBL] [Abstract][Full Text] [Related]
7. Integration of outpatient infectious diseases clinic pharmacy services and specialty pharmacy services for patients with HIV infection.
Gilbert EM; Gerzenshtein L
Am J Health Syst Pharm; 2016 Jun; 73(11):757-63. PubMed ID: 27126831
[TBL] [Abstract][Full Text] [Related]
8. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
9. Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Habibi M; Kuttab HM
Am J Health Syst Pharm; 2016 Jun; 73(11):811-9. PubMed ID: 27126827
[TBL] [Abstract][Full Text] [Related]
10. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
Middendorff G; Elsey R; Lounsbery B; Chadwell R
J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
[TBL] [Abstract][Full Text] [Related]
11. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A
Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269
[TBL] [Abstract][Full Text] [Related]
12. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
13. Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Hanson RL; Habibi M; Khamo N; Abdou S; Stubbings J
Am J Health Syst Pharm; 2014 Mar; 71(6):463-9. PubMed ID: 24589537
[TBL] [Abstract][Full Text] [Related]
14. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
15. Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center.
Tuffaha HW; Koopmans SM
J Oncol Pharm Pract; 2012 Jun; 18(2):180-5. PubMed ID: 21862687
[TBL] [Abstract][Full Text] [Related]
16. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
17. Development of a specialty medication prior-authorization service at an urban academic medical center.
Martin MT; Telebak E; Taylor PA; Volozhina O
Am J Health Syst Pharm; 2016 Aug; 73(15):1174-9. PubMed ID: 27440624
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review.
Marchetti M
Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):469-480. PubMed ID: 28796569
[TBL] [Abstract][Full Text] [Related]
19. Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center.
Farano JL; Kandah HM
J Manag Care Spec Pharm; 2019 Jul; 25(7):765-769. PubMed ID: 31232209
[TBL] [Abstract][Full Text] [Related]
20. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services.
Zuckerman AD; Mourani J; Smith A; Ortega M; Donovan JL; Gazda NP; Tong K; Simonson D; Kelley T; DeClercq J; Choi L; Pierce G
Am J Health Syst Pharm; 2023 Jun; 80(13):827-841. PubMed ID: 36999452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
